1
|
Su SL, Miao XD, Li JS, Zhao LH, Fan RY, Shang EX, Zhu Y, Qian DW, Duan JA. [Combination characteristics of frankincense and myrrh and progress and prospect of their combination efficacy and mechanism]. Zhongguo Zhong Yao Za Zhi 2022; 47:5789-5796. [PMID: 36471996 DOI: 10.19540/j.cnki.cjcmm.20220801.601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
Herbal pair is formed based on the experience summary of doctors' deep understanding and perception of the medicinal nature in long-term clinical practice. It gradually becomes the exquisite structural unit for preparing traditional Chinese medicine(TCM) prescriptions, and often plays a core bridge role in the prescription combination. Frankincense and myrrh are raw resin materials of incense abroad, which are subsequently included as Chinese medicinal herbs and endowed with rich medicinal connotation. With the functions of relaxing Zang-fu organs, activating blood and relieving pain, they have definite clinical efficacy. From the perspective of herbal description and clinical application, this study systematically analyzed the combination of frankincense and myrrh as well as their combination proportion, efficacy characterization, diseases and syndromes, effective components and action mechanism. On this basis, the focus of in-depth research of frankincense-myrrh and the application prospects were proposed, in order to further reveal the potential meditation law of this herbal pair, thus contributing to clinical practice and drug innovation of traditional Chinese medicine, and providing reference for understanding of TCM medicinal nature and research of herbal pairs.
Collapse
Affiliation(s)
- Shu-Lan Su
- Jiangsu Blood-regulating Prescription Innovative Drug Engineering Center, Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,National-Local Joint Engineering Research Center of Resourcs Industrialization of Chinese Meteria Medica and Prescription-oriented Innovative Drugs, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine Nanjing 210023, China
| | - Xiao-Dong Miao
- Jiangsu Blood-regulating Prescription Innovative Drug Engineering Center, Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,National-Local Joint Engineering Research Center of Resourcs Industrialization of Chinese Meteria Medica and Prescription-oriented Innovative Drugs, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine Nanjing 210023, China
| | - Jia-Shang Li
- Jiangsu Blood-regulating Prescription Innovative Drug Engineering Center, Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,National-Local Joint Engineering Research Center of Resourcs Industrialization of Chinese Meteria Medica and Prescription-oriented Innovative Drugs, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine Nanjing 210023, China
| | - Li-Hui Zhao
- Jiangsu Blood-regulating Prescription Innovative Drug Engineering Center, Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,National-Local Joint Engineering Research Center of Resourcs Industrialization of Chinese Meteria Medica and Prescription-oriented Innovative Drugs, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine Nanjing 210023, China
| | - Ruo-Ying Fan
- Jiangsu Blood-regulating Prescription Innovative Drug Engineering Center, Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,National-Local Joint Engineering Research Center of Resourcs Industrialization of Chinese Meteria Medica and Prescription-oriented Innovative Drugs, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine Nanjing 210023, China
| | - Er-Xin Shang
- Jiangsu Blood-regulating Prescription Innovative Drug Engineering Center, Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,National-Local Joint Engineering Research Center of Resourcs Industrialization of Chinese Meteria Medica and Prescription-oriented Innovative Drugs, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine Nanjing 210023, China
| | - Yue Zhu
- Jiangsu Blood-regulating Prescription Innovative Drug Engineering Center, Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,National-Local Joint Engineering Research Center of Resourcs Industrialization of Chinese Meteria Medica and Prescription-oriented Innovative Drugs, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine Nanjing 210023, China
| | - Da-Wei Qian
- Jiangsu Blood-regulating Prescription Innovative Drug Engineering Center, Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,National-Local Joint Engineering Research Center of Resourcs Industrialization of Chinese Meteria Medica and Prescription-oriented Innovative Drugs, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine Nanjing 210023, China
| | - Jin-Ao Duan
- Jiangsu Blood-regulating Prescription Innovative Drug Engineering Center, Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,National-Local Joint Engineering Research Center of Resourcs Industrialization of Chinese Meteria Medica and Prescription-oriented Innovative Drugs, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine Nanjing 210023, China
| |
Collapse
|
2
|
Li JS, Zhao ZZ, Miao XD, Su SL, Shang EX, Qian DW, Duan JA. [Mechanism of Olibanum-Myrrha in treatment of rheumatoid arthritis based on network pharmacology and molecular docking]. Zhongguo Zhong Yao Za Zhi 2021; 46:2371-2379. [PMID: 34047081 DOI: 10.19540/j.cnki.cjcmm.20201126.401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
In this paper, network pharmacology method and molecular docking technique were used to investigate the target genes of Olibanum and Myrrha compatibility and the possible mechanism of action in the treatment of rheumatoid arthritis(RA). Our team obtained the main active components of Olibanum-Myrrha based on literatures study, relevant traditional Chinese medicine systematic pharmacological databases and literature retrieval, and made target prediction of the active components through SwissTargetPrediction database. At the same time, RA-related targets were collected through DrugBank, GeneCards and Therapeutic Target Database(TDD) databases; and VENNY 2.1 was use to collect intersection targets to map common targets of drug and disease of Venn diagram online. The team used STRING database to construct PPI protein interaction network diagram, and screen out core targets according to the size of the interaction, and Cytoscape 3.6.0 software was used to construct network models of "traditional Chinese medicine-component-target" "traditional Chinese medicine-component-target-disease" and core target interaction network model. The intersection target was analyzed by using DAVID 6.8 online database for GO function analysis and KEGG pathway enrichment analysis, and Pathon was used to visualization. AutoDock Vina and Pymol were used to connect the core active components with the core targets. Sixteen active components of Olibanum-Myrrha pairs were found and collected in the laboratory, and 320 relevant potential targets, 468 RA-related targets and 62 intersection targets were obtained through the Venn diagram. It mainly acted on multiple targets, such as IL6, TNF, IL1 B and MAPK1, involving TNF signaling pathway and Toll-like receptor signaling pathway in RA treatment. Finally, in this study, possible targets and signaling pathways of Olibanum-Myrrha compatibility therapy for RA were discussed, and molecular docking between core targets and core active components was conducted, which could provide scientific basis for the study on the mechanism of Olibanum-Myrrha compatibility.
Collapse
Affiliation(s)
- Jia-Shang Li
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization,National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine,Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,Nanjing University of Chinese Medicine Nanjing 210023,China
| | - Zi-Zhang Zhao
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization,National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine,Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,Nanjing University of Chinese Medicine Nanjing 210023,China
| | - Xiao-Dong Miao
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization,National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine,Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,Nanjing University of Chinese Medicine Nanjing 210023,China
| | - Shu-Lan Su
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization,National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine,Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,Nanjing University of Chinese Medicine Nanjing 210023,China
| | - Er-Xin Shang
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization,National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine,Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,Nanjing University of Chinese Medicine Nanjing 210023,China
| | - Da-Wei Qian
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization,National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine,Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,Nanjing University of Chinese Medicine Nanjing 210023,China
| | - Jin-Ao Duan
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization,National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine,Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae,Nanjing University of Chinese Medicine Nanjing 210023,China
| |
Collapse
|
3
|
Miao XD, Zheng LJ, Zhao ZZ, Su SL, Zhu Y, Guo JM, Shang EX, Qian DW, Duan JA. Protective Effect and Mechanism of Boswellic Acid and Myrrha Sesquiterpenes with Different Proportions of Compatibility on Neuroinflammation by LPS-Induced BV2 Cells Combined with Network Pharmacology. Molecules 2019; 24:molecules24213946. [PMID: 31683684 PMCID: PMC6864549 DOI: 10.3390/molecules24213946] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Revised: 10/28/2019] [Accepted: 10/29/2019] [Indexed: 11/16/2022] Open
Abstract
Frankincense and myrrha (FM), commonly used as a classical herbal pair, have a wide range of clinical applications and definite anti-inflammatory activity. However, anti-neuroinflammation effects and mechanisms are not clear. In this study, we adopted a lipopolysaccharide (LPS)-induced microglial (BV2) cell model and a network pharmacology method to reveal the anti-neuroinflammatory effects and mechanisms of boswellic acid (BA) and myrrha sesquiterpenes (MS) with different proportions of compatibility. The data showed that the different ratios of BA and MS had different degrees of inhibition of interleukin-1β (IL-1β), IL-6, and inducible nitric oxide synthase (iNOS) mRNA expression, down-regulated the phosphor-nuclear factor kappa B/nuclear factor kappa B (p-NF-ҡB)/(NF-ҡB), phosphorylated protein kinase b/protein kinase b (p-AKT/AKT), and Toll-like receptor 4 (TLR4) protein expression levels, and increased phospho-PI3 kinase (p-PI3K) protein expression levels. When the ratios of BA and MS were 10:1, 5:1, and 20:1, better effective efficacy was exhibited. According to the correlation analysis between the effect index and bioactive substances, it was suggested that 2-methoxy-5-acetoxy -fruranogermacr-1(10)-en-6-one (Compound 1), 3α-acetyloxylanosta-8,24-dien-21-oic acid (Compound 2), 11-keto-boswellic acid (Compound 3), and 3-acetyl-11-keto-β -boswellic acid (Compound 4) made important contributions to the treatment of neuroinflammation. Furthermore, based on the network pharmacological analysis, it was found that these four active compounds acted on 31 targets related to neuroinflammation and were involved in 32 signaling pathways which mainly related to the immune system, cardiovascular system, and nervous system, suggesting that BA and MS could be used to treat neuroinflammation.
Collapse
Affiliation(s)
- Xiao-Dong Miao
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| | - Li-Jie Zheng
- Jiangsu Key Laboratory of Research and Development in Marine Bio-resource Pharmaceutics, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| | - Zi-Zhang Zhao
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| | - Shu-Lan Su
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| | - Yue Zhu
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| | - Jian-Ming Guo
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| | - Er-Xin Shang
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| | - Da-Wei Qian
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| | - Jin-Ao Duan
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| |
Collapse
|
4
|
Zhang Q, Cao L, Wu YP, Miao XD. Inflammatory responses and biological characteristics of human osteosarcoma cells and umbilical cord blood mononuclear cells in co-cultured microenvironment. J BIOL REG HOMEOS AG 2019; 33:857-862. [PMID: 31210050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Affiliation(s)
- Q Zhang
- Foot and Ankle Group of Department of Orthopaedics, the Second Hospital Affiliated to Zhejiang University School of Medicine, HangZhou, Zhejiang University, China
| | - L Cao
- Foot and Ankle Group of Department of Orthopaedics, the Second Hospital Affiliated to Zhejiang University School of Medicine, HangZhou, Zhejiang University, China
| | - Y P Wu
- Foot and Ankle Group of Department of Orthopaedics, the Second Hospital Affiliated to Zhejiang University School of Medicine, HangZhou, Zhejiang University, China
| | - X D Miao
- Foot and Ankle Group of Department of Orthopaedics, the Second Hospital Affiliated to Zhejiang University School of Medicine, HangZhou, Zhejiang University, China
| |
Collapse
|
5
|
Zhang Q, Cao L, Miao XD, Wu YP. Diagnostic value of TRACP5b expression in patients with bone tumors. J BIOL REG HOMEOS AG 2019; 33:557-562. [PMID: 30973000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
In order to investigate the diagnostic value of serum levels of tartrate-resistant acid phosphatase 5b (TRACP5b) in patients with bone tumors, enzyme linked immunosorbent assay (ELISA) was used to com¬pare serum levels of TRACP5b and alkaline phosphatase (ALP) in bone tumor patients (experimental group, 80 cases) and healthy controls (control group, 36 cases). It was found that the serum level of TRACP5b in the experimental group was significantly higher than that in the control group. In addition, the sensitivity and specificity of serum TRACP5b were higher than those of serum ALP in the diagnosis of bone tumors. Fur¬thermore, the serum level of TRACP5b was positively correlated with that of ALP. Therefore, it was conclud¬ed that the serum level of TRACP5b may be used as a sensitive indicator of bone tumors, and the sensitivity and specificity of TRACP5b are even higher than those of ALP in the diagnosis of bone tumors.
Collapse
Affiliation(s)
- Q Zhang
- Foot and Ankle Group of Department of Orthopaedics, The Second Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, Zhejiang University, China
| | - L Cao
- Foot and Ankle Group of Department of Orthopaedics, The Second Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, Zhejiang University, China
| | - X D Miao
- Foot and Ankle Group of Department of Orthopaedics, The Second Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, Zhejiang University, China
| | - Y P Wu
- Foot and Ankle Group of Department of Orthopaedics, The Second Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, Zhejiang University, China
| |
Collapse
|